PRECLINICAL PROFILE OF THE PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITOR GS-9857

被引：23

作者：

Taylor, J. G. ^{[1
]}

Appleby, T. ^{[1
]}

Barauskas, O. ^{[1
]}

Chen, X. ^{[1
]}

Dvory-Sobol, H. ^{[1
]}

Gong, R. ^{[1
]}

Lee, J. ^{[1
]}

Nejati, E. ^{[1
]}

Schultz, B. ^{[1
]}

Wang, Y. ^{[1
]}

Yang, C. ^{[1
]}

Yu, M. ^{[1
]}

Zipfel, S. ^{[1
]}

Chan, K. ^{[1
]}

机构：

[1] Gilead Sci Inc, Foster City, CA 94404 USA

来源：

JOURNAL OF HEPATOLOGY | 2015年 / 62卷

关键词：

D O I：

10.1016/S0168-8278(15)31102-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0899

引用

页码：S681 / S681

页数：1

共 50 条

[21] PHARMACOKINETIC INTERACTION OF HCV NS3/4A PROTEASE INHIBITOR VANIPREVIR AND ROSUVASTATIN.
Orito, Y.
Iwasa, T.
Uemura, N.
Fujimoto, G.
Yama, S.
Gao, W.
Caro, L.
Fandozzi, C.
Prucksaritanont, T.
Anderson, M.
Butterton, J.
Hasegawa, S.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S24 - S25
[22] The Antiviral Profile of TG-2349, a novel HCV Protease Inhibitor with Pan-Genotypic Activity
Chen, Chih-Ming
Chen, Yi-Fen
Lin, Chu-Chung
King, Chi-Hsin R.
Hsu, Ming-Chu
HEPATOLOGY, 2014, 60 : 1172A - 1172A
[23] Discovery of the novel HCV NS3 protease inhibitor, GS-9451
Pyun, Hyungjung
Sheng, Christopher
Appleby, Todd
Barauskas, Ona
Butler, Thomas
Cai, Ruby
Chen, Xiaowu
Cho, Aesop
Clarke, Michael
Corsa, Amy
Doerffler, Edward
Hung, Magdeleine
Ji, Mingzhe
Link, John
Liu, Xiaohong
Pakdaman, Rowchanak
Robinson, Margaret
Schultz, Brian
Tay, Chin
Wu, Qiaoyin
Xu, Jie
Yang, Chris
Yang, Huiling
Delaney, William
Kim, Choung
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[24] Discovery of BMS-986160 as a second-generation inhibitor of the hepatitis C virus NS3/4A with pan-genotypic antiviral activity
Sun, Li-Qiang
Mull, Eric
Kandhasamy, Sarkunam
Baratam, Venkata Rao
Puttaswamy, Sunitha
Pulicharla, Nagalakshmi
Vishwakrishnan, Sureshbabu
Reddy, Subba
Trivedi, Ravi
Sinha, Sarmistha
Sivaprasad, Sankar
Rao, Abhijith
Desai, Salil
Ghosh, Kaushik
Rajamani, Ramkumar
Wang, Ying-Kai
Fang, Hua
Mathur, Arvind
Rampulla, Richard
Jenkins, Susan
Meanwell, Nicholas
McPhee, Fiona
Scola, Paul
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
[25] Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor
Rosenquist, Asa
Samuelsson, Bertil
Johansson, Per-Ola
Cummings, Maxwell D.
Lenz, Oliver
Raboisson, Pierre
Simmen, Kenny
Vendeville, Sandrine
de Kock, Herman
Nilsson, Magnus
Horvath, Andras
Kalmeijer, Ronald
de la Rosa, Guy
Beumont-Mauviel, Maria
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1673 - 1693
[26] Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor
Matthews, Samuel James
Lancaster, Jason W.
CLINICAL THERAPEUTICS, 2012, 34 (09) : 1857 - 1882
[27] Second-generation inhibitors of the hepatitis C virus NS3/4A protease: Discovery of BMS-986144 with pan-genotypic antiviral activity
Sun, Li-Qiang
Mull, Eric
Zhao, Qian
Gillis, Eric
Bowsher, Michael
D'Andrea, Stanley
Zheng, Zhizhen
Wang, Xiangdong
Mathur, Arvind
Rampulla, Richard
Kandhasamy, Sarkunam
Pulicharla, Nagalakshmi
Vishwakrishnan, Sureshbabu
Reddy, Subba
Trivedi, Ravi
Sinha, Sarmistha
Rao, Abhijith
Desai, Salil
Ghosh, Kaushik
Rajamani, Ramkumar
Friborg, Jacques
Levine, Steven
Chen, Chaoqun
Falk, Paul
Wang, Ying-Kai
Fang, Hua
Jenkins, Susan
Kramer, Melissa
Haskell, Roy
Johnson, Kimberly
Loy, James
Levesqu, Paul
Zhu, Jia
Cockett, Mark
Meanwell, Nicholas
McPhee, Fiona
Scola, Paul
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[28] Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease
Soumana, Djade I.
Ali, Akbar
Schiffer, Celia A.
ACS CHEMICAL BIOLOGY, 2014, 9 (11) : 2485 - 2490
[29] Boceprevir, an NS3 Protease Inhibitor of HCV
Berman, Kenneth
Kwo, Paul Y.
CLINICS IN LIVER DISEASE, 2009, 13 (03) : 429 - +
[30] Treatment of HCV infection with the novel NS3/4A protease inhibitors
De Luca, Andrea
Bianco, Claudia
Rossetti, Barbara
CURRENT OPINION IN PHARMACOLOGY, 2014, 18 : 9 - 17

← 1 2 3 4 5 →